La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Dopaminergic axon guidance: which makes what?

Identifieur interne : 000814 ( PubMed/Curation ); précédent : 000813; suivant : 000815

Dopaminergic axon guidance: which makes what?

Auteurs : Laetitia Prestoz [France] ; Mohamed Jaber ; Afsaneh Gaillard

Source :

RBID : pubmed:22866028

Abstract

Mesotelencephalic pathways in the adult central nervous system have been studied in great detail because of their implication in major physiological functions as well as in psychiatric, neurological, and neurodegenerative diseases. However, the ontogeny of these pathways and the molecular mechanisms that guide dopaminergic axons during embryogenesis have been only recently studied. This line of research is of crucial interest for the repair of lesioned circuits in adulthood following neurodegenerative diseases or common traumatic injuries. For instance, in the adult, the anatomic and functional repair of the nigrostriatal pathway following dopaminergic embryonic neuron transplantation suggests that specific guidance cues exist which govern embryonic fibers outgrowth, and suggests that axons from transplanted embryonic cells are able to respond to theses cues, which then guide them to their final targets. In this review, we first synthesize the work that has been performed in the last few years on developing mesotelencephalic pathways, and summarize the current knowledge on the identity of cellular and molecular signals thought to be involved in establishing mesotelencephalic dopaminergic neuronal connectivity during embryogenesis in the central nervous system of rodents. Then, we review the modulation of expression of these molecular signals in the lesioned adult brain and discuss their potential role in remodeling the mesotelencephalic dopaminergic circuitry, with a particular focus on Parkinson's disease (PD). Identifying guidance molecules involved in the connection of grafted cells may be useful for cellular therapy in Parkinsonian patients, as these molecules may help direct axons from grafted cells along the long distance they have to travel from the substantia nigra to the striatum.

DOI: 10.3389/fncel.2012.00032
PubMed: 22866028

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:22866028

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Dopaminergic axon guidance: which makes what?</title>
<author>
<name sortKey="Prestoz, Laetitia" sort="Prestoz, Laetitia" uniqKey="Prestoz L" first="Laetitia" last="Prestoz">Laetitia Prestoz</name>
<affiliation wicri:level="1">
<nlm:affiliation>Experimental and Clinical Neurosciences Laboratory, Research Group on Cellular Therapies in Brain Diseases, INSERM U1084, University of Poitiers Poitiers, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Experimental and Clinical Neurosciences Laboratory, Research Group on Cellular Therapies in Brain Diseases, INSERM U1084, University of Poitiers Poitiers</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Jaber, Mohamed" sort="Jaber, Mohamed" uniqKey="Jaber M" first="Mohamed" last="Jaber">Mohamed Jaber</name>
</author>
<author>
<name sortKey="Gaillard, Afsaneh" sort="Gaillard, Afsaneh" uniqKey="Gaillard A" first="Afsaneh" last="Gaillard">Afsaneh Gaillard</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22866028</idno>
<idno type="pmid">22866028</idno>
<idno type="doi">10.3389/fncel.2012.00032</idno>
<idno type="wicri:Area/PubMed/Corpus">000850</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000850</idno>
<idno type="wicri:Area/PubMed/Curation">000814</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000814</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Dopaminergic axon guidance: which makes what?</title>
<author>
<name sortKey="Prestoz, Laetitia" sort="Prestoz, Laetitia" uniqKey="Prestoz L" first="Laetitia" last="Prestoz">Laetitia Prestoz</name>
<affiliation wicri:level="1">
<nlm:affiliation>Experimental and Clinical Neurosciences Laboratory, Research Group on Cellular Therapies in Brain Diseases, INSERM U1084, University of Poitiers Poitiers, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Experimental and Clinical Neurosciences Laboratory, Research Group on Cellular Therapies in Brain Diseases, INSERM U1084, University of Poitiers Poitiers</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Jaber, Mohamed" sort="Jaber, Mohamed" uniqKey="Jaber M" first="Mohamed" last="Jaber">Mohamed Jaber</name>
</author>
<author>
<name sortKey="Gaillard, Afsaneh" sort="Gaillard, Afsaneh" uniqKey="Gaillard A" first="Afsaneh" last="Gaillard">Afsaneh Gaillard</name>
</author>
</analytic>
<series>
<title level="j">Frontiers in cellular neuroscience</title>
<idno type="eISSN">1662-5102</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Mesotelencephalic pathways in the adult central nervous system have been studied in great detail because of their implication in major physiological functions as well as in psychiatric, neurological, and neurodegenerative diseases. However, the ontogeny of these pathways and the molecular mechanisms that guide dopaminergic axons during embryogenesis have been only recently studied. This line of research is of crucial interest for the repair of lesioned circuits in adulthood following neurodegenerative diseases or common traumatic injuries. For instance, in the adult, the anatomic and functional repair of the nigrostriatal pathway following dopaminergic embryonic neuron transplantation suggests that specific guidance cues exist which govern embryonic fibers outgrowth, and suggests that axons from transplanted embryonic cells are able to respond to theses cues, which then guide them to their final targets. In this review, we first synthesize the work that has been performed in the last few years on developing mesotelencephalic pathways, and summarize the current knowledge on the identity of cellular and molecular signals thought to be involved in establishing mesotelencephalic dopaminergic neuronal connectivity during embryogenesis in the central nervous system of rodents. Then, we review the modulation of expression of these molecular signals in the lesioned adult brain and discuss their potential role in remodeling the mesotelencephalic dopaminergic circuitry, with a particular focus on Parkinson's disease (PD). Identifying guidance molecules involved in the connection of grafted cells may be useful for cellular therapy in Parkinsonian patients, as these molecules may help direct axons from grafted cells along the long distance they have to travel from the substantia nigra to the striatum.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">22866028</PMID>
<DateCreated>
<Year>2012</Year>
<Month>08</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2012</Year>
<Month>10</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>08</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1662-5102</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>6</Volume>
<PubDate>
<Year>2012</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in cellular neuroscience</Title>
<ISOAbbreviation>Front Cell Neurosci</ISOAbbreviation>
</Journal>
<ArticleTitle>Dopaminergic axon guidance: which makes what?</ArticleTitle>
<Pagination>
<MedlinePgn>32</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fncel.2012.00032</ELocationID>
<Abstract>
<AbstractText>Mesotelencephalic pathways in the adult central nervous system have been studied in great detail because of their implication in major physiological functions as well as in psychiatric, neurological, and neurodegenerative diseases. However, the ontogeny of these pathways and the molecular mechanisms that guide dopaminergic axons during embryogenesis have been only recently studied. This line of research is of crucial interest for the repair of lesioned circuits in adulthood following neurodegenerative diseases or common traumatic injuries. For instance, in the adult, the anatomic and functional repair of the nigrostriatal pathway following dopaminergic embryonic neuron transplantation suggests that specific guidance cues exist which govern embryonic fibers outgrowth, and suggests that axons from transplanted embryonic cells are able to respond to theses cues, which then guide them to their final targets. In this review, we first synthesize the work that has been performed in the last few years on developing mesotelencephalic pathways, and summarize the current knowledge on the identity of cellular and molecular signals thought to be involved in establishing mesotelencephalic dopaminergic neuronal connectivity during embryogenesis in the central nervous system of rodents. Then, we review the modulation of expression of these molecular signals in the lesioned adult brain and discuss their potential role in remodeling the mesotelencephalic dopaminergic circuitry, with a particular focus on Parkinson's disease (PD). Identifying guidance molecules involved in the connection of grafted cells may be useful for cellular therapy in Parkinsonian patients, as these molecules may help direct axons from grafted cells along the long distance they have to travel from the substantia nigra to the striatum.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Prestoz</LastName>
<ForeName>Laetitia</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Experimental and Clinical Neurosciences Laboratory, Research Group on Cellular Therapies in Brain Diseases, INSERM U1084, University of Poitiers Poitiers, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jaber</LastName>
<ForeName>Mohamed</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gaillard</LastName>
<ForeName>Afsaneh</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>07</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Front Cell Neurosci</MedlineTA>
<NlmUniqueID>101477935</NlmUniqueID>
<ISSNLinking>1662-5102</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2011 Dec 22;480(7378):547-51</RefSource>
<PMID Version="1">22056989</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Genet. 2007 Jun;3(6):e98</RefSource>
<PMID Version="1">17571925</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 1983 Jun;9(2):373-81</RefSource>
<PMID Version="1">6877599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1981 Jun 1;198(4):677-716</RefSource>
<PMID Version="1">7251936</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Dis. 1997;4(3-4):186-200</RefSource>
<PMID Version="1">9361295</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1997 Oct 17;771(2):238-50</RefSource>
<PMID Version="1">9401744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1997 Dec 5;778(1):194-205</RefSource>
<PMID Version="1">9462892</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1998 Dec 1;18(23):9962-76</RefSource>
<PMID Version="1">9822752</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1999 Mar 15;19(6):2090-101</RefSource>
<PMID Version="1">10066262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 1999 Mar 27;823(1-2):67-79</RefSource>
<PMID Version="1">10095013</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 1999 May 12;52(8):1720-1</RefSource>
<PMID Version="1">10331717</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 1999;91(1):193-201</RefSource>
<PMID Version="1">10336070</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1999 Jun 15;19(12):4962-71</RefSource>
<PMID Version="1">10366629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Histochem Cytochem. 1999 Jul;47(7):855-61</RefSource>
<PMID Version="1">10375373</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2000 Jan;25(1):29-41</RefSource>
<PMID Version="1">10707970</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2000 Jun 1;20(11):4112-9</RefSource>
<PMID Version="1">10818146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2000 Sep 1;20(17):6501-16</RefSource>
<PMID Version="1">10964956</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2002 Jan 17;33(2):233-48</RefSource>
<PMID Version="1">11804571</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Development. 2002 Feb;129(3):761-73</RefSource>
<PMID Version="1">11830575</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2004 Dec 16;44(6):961-75</RefSource>
<PMID Version="1">15603739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Neurosci. 2005 Feb;28(2):275-91</RefSource>
<PMID Version="1">15691709</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>NeuroRx. 2004 Oct;1(4):382-93</RefSource>
<PMID Version="1">15717042</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2005;131(3):671-81</RefSource>
<PMID Version="1">15730872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Neurosci. 2005 Mar;28(3):547-55</RefSource>
<PMID Version="1">15737744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Neurosci. 2005 Apr;8(4):451-7</RefSource>
<PMID Version="1">15778712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 2005 Jun 13;486(4):318-30</RefSource>
<PMID Version="1">15846787</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2005 May;21(9):2336-46</RefSource>
<PMID Version="1">15932593</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2005 Jul 6;25(27):6467-77</RefSource>
<PMID Version="1">16000637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2005 Oct 14;310(5746):317-20</RefSource>
<PMID Version="1">16224024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Hum Genet. 2005 Nov;77(5):685-93</RefSource>
<PMID Version="1">16252231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2005 Nov;22(9):2134-44</RefSource>
<PMID Version="1">16262652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Development. 2005 Dec;132(24):5527-37</RefSource>
<PMID Version="1">16291793</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 2006 Jan 5;1067(1):67-77</RefSource>
<PMID Version="1">16360648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Neurobiol. 2006 Feb;16(1):59-66</RefSource>
<PMID Version="1">16417998</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Development. 2006 May;133(9):1799-809</RefSource>
<PMID Version="1">16571630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Pharmacol. 2006 Jul;70(1):71-7</RefSource>
<PMID Version="1">16595738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2006 Apr;23(7):1721-30</RefSource>
<PMID Version="1">16623828</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2006 May;23(9):2247-54</RefSource>
<PMID Version="1">16706833</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res Rev. 2006 Sep;52(2):327-45</RefSource>
<PMID Version="1">16774788</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Stem Cells. 2006 Nov;24(11):2504-13</RefSource>
<PMID Version="1">16840550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2006 Sep;5(9):796-802</RefSource>
<PMID Version="1">16914408</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Biosci. 2007;12:492-506</RefSource>
<PMID Version="1">17127312</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Neurosci. 2007 Jan;8(1):21-32</RefSource>
<PMID Version="1">17180160</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Neurobiol. 2007 Jun;82(2):57-79</RefSource>
<PMID Version="1">17537564</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Dev Biol. 2007;7:98</RefSource>
<PMID Version="1">17727705</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res. 2007 Nov 28;1182:60-72</RefSource>
<PMID Version="1">17945206</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2007 Dec 19;150(4):764-73</RefSource>
<PMID Version="1">17996376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 2008 Jan 20;506(3):387-97</RefSource>
<PMID Version="1">18041777</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5856-61</RefSource>
<PMID Version="1">18391196</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res Mol Brain Res. 2000 Nov 10;83(1-2):81-93</RefSource>
<PMID Version="1">11072098</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 1995 Jul;15(1):35-44</RefSource>
<PMID Version="1">7619528</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Transplant. 1995 Jan-Feb;4(1):103-12</RefSource>
<PMID Version="1">7728324</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 1996 Nov 15;16(22):7216-27</RefSource>
<PMID Version="1">8929430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Neurosci. 1997;8(6):417-29</RefSource>
<PMID Version="1">9143559</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):171-8</RefSource>
<PMID Version="1">11146119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2001 May 22;98(11):6423-8</RefSource>
<PMID Version="1">11353855</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2001 Jun 15;21(12):4272-80</RefSource>
<PMID Version="1">11404412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 2002 Jan 7;442(2):130-55</RefSource>
<PMID Version="1">11754167</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Neurol. 1992 Jun;116(3):275-85</RefSource>
<PMID Version="1">1350253</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 1988 Jun;25(3):857-87</RefSource>
<PMID Version="1">3405431</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1981 Jun 20;199(2):233-53</RefSource>
<PMID Version="1">6114114</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 1981 Jun 20;199(2):255-76</RefSource>
<PMID Version="1">6114115</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10777-82</RefSource>
<PMID Version="1">12124402</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Brain Res. 2002;138:17-38</RefSource>
<PMID Version="1">12432760</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2002 Dec;16(12):2351-7</RefSource>
<PMID Version="1">12492430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hippocampus. 2003;13(1):1-20</RefSource>
<PMID Version="1">12625453</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell. 2003 May 2;113(3):285-99</RefSource>
<PMID Version="1">12732138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Neurol. 2003 Jul;182(1):103-12</RefSource>
<PMID Version="1">12821380</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2003 Aug 27;23(21):7789-800</RefSource>
<PMID Version="1">12944508</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2004 Feb;19(4):831-44</RefSource>
<PMID Version="1">15009130</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Res Mol Brain Res. 2004 Apr 7;123(1-2):104-11</RefSource>
<PMID Version="1">15046871</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2004 Mar;19(6):1494-504</RefSource>
<PMID Version="1">15066146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Neurobiol. 2004 Jun;14(3):288-96</RefSource>
<PMID Version="1">15194108</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Neurosci. 2004 Jul;26(3):418-28</RefSource>
<PMID Version="1">15234346</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Comp Neurol. 2004 Aug 23;476(3):301-11</RefSource>
<PMID Version="1">15269972</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Neurosci. 2007 May;30(5):194-202</RefSource>
<PMID Version="1">17408759</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Pathol. 2009 Jan;19(1):91-107</RefSource>
<PMID Version="1">18462474</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2008;3(7):e2707</RefSource>
<PMID Version="1">18628988</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dev Neurobiol. 2009 Jan;69(1):36-46</RefSource>
<PMID Version="1">19003794</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci Res. 2009 May 15;87(7):1620-33</RefSource>
<PMID Version="1">19115401</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2009 Apr 1;29(13):4044-55</RefSource>
<PMID Version="1">19339600</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurosurgery. 2009 Apr;64(4):602-12; discussion 612-3</RefSource>
<PMID Version="1">19349823</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Development. 2009 Jun;136(12):2027-38</RefSource>
<PMID Version="1">19439492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Neurobiol. 2009 Jun;19(3):263-74</RefSource>
<PMID Version="1">19541473</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Neurol. 2009 Oct;219(2):466-80</RefSource>
<PMID Version="1">19576892</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Dis. 2009 Sep;35(3):477-88</RefSource>
<PMID Version="1">19616502</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Mol Genet. 2009 Oct 15;18(20):3955-68</RefSource>
<PMID Version="1">19625296</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Neurosci. 2009 Aug;30(4):625-38</RefSource>
<PMID Version="1">19674082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2009;4(9):e7007</RefSource>
<PMID Version="1">19774071</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2009 Oct 7;29(40):12542-57</RefSource>
<PMID Version="1">19812329</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci Res. 2010 Apr;88(5):971-80</RefSource>
<PMID Version="1">19859963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2009 Dec;66(6):792-8</RefSource>
<PMID Version="1">20035503</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2010 Feb;133(Pt 2):482-95</RefSource>
<PMID Version="1">20123725</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Neurosci. 2010 Jun;44(2):135-53</RefSource>
<PMID Version="1">20298787</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cold Spring Harb Perspect Biol. 2010 May;2(5):a001941</RefSource>
<PMID Version="1">20452961</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurotrauma. 2010 Jul;27(7):1321-32</RefSource>
<PMID Version="1">20486805</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuroscience. 2010 Aug 25;169(2):932-49</RefSource>
<PMID Version="1">20493932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cold Spring Harb Perspect Biol. 2010 Jul;2(7):a001867</RefSource>
<PMID Version="1">20519341</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2010;5(7):e11463</RefSource>
<PMID Version="1">20628609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Neurosci. 2010 Dec;45(4):324-34</RefSource>
<PMID Version="1">20637284</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Front Neuroanat. 2010;4. pii: 25. doi: 10.3389/fnana.2010.00025</RefSource>
<PMID Version="1">20700382</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Neurosci. 2010;11:105</RefSource>
<PMID Version="1">20738842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Brain Res. 2010;184:221-35</RefSource>
<PMID Version="1">20887878</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prog Brain Res. 2010;184:237-64</RefSource>
<PMID Version="1">20887879</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hum Genet. 2011 Feb;56(2):125-9</RefSource>
<PMID Version="1">21085126</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2010 Nov 24;30(47):16053-64</RefSource>
<PMID Version="1">21106844</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Neurosci. 2011 Jan;46(1):347-56</RefSource>
<PMID Version="1">21118670</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Neurosci. 2011 Mar;34(3):124-33</RefSource>
<PMID Version="1">21316770</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Psychiatry Neurosci. 2011 Sep;36(5):296-310</RefSource>
<PMID Version="1">21481303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2011;6(3):e18373</RefSource>
<PMID Version="1">21483795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58</RefSource>
<PMID Version="1">21495962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurosci. 2011 Jun 8;31(23):8381-94</RefSource>
<PMID Version="1">21653843</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurotherapeutics. 2011 Oct;8(4):539-48</RefSource>
<PMID Version="1">21901584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2011;6(9):e24636</RefSource>
<PMID Version="1">21931787</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC3408579</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Parkinson's disease</Keyword>
<Keyword MajorTopicYN="N">axon guidance</Keyword>
<Keyword MajorTopicYN="N">development</Keyword>
<Keyword MajorTopicYN="N">dopamine</Keyword>
<Keyword MajorTopicYN="N">mesotelencephalic pathway</Keyword>
<Keyword MajorTopicYN="N">transplantation</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2012</Year>
<Month>02</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2012</Year>
<Month>07</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2012</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2012</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">22866028</ArticleId>
<ArticleId IdType="doi">10.3389/fncel.2012.00032</ArticleId>
<ArticleId IdType="pmc">PMC3408579</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000814 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000814 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:22866028
   |texte=   Dopaminergic axon guidance: which makes what?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:22866028" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024